Loopbaan van Mark Hernon
Eerdere bekende functies van Mark Hernon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RUBIUS THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 | 01-09-2022 |
| BIOGEN INC. | Hoofd Techniek/Wetenschap/O&O | 04-12-2017 | 01-03-2021 |
Opleiding van Mark Hernon
| Rensselaer Polytechnic Institute | Graduate Degree |
| The Lally School of Management & Technology | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Beurs
- Insiders
- Mark Hernon
- Ervaring